Arkolith/Insider Trading/ALMR/Form 4

Illumina Innovation Fund II GP, L.L.C.

10% OwnerAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
Net Buying
Open-Market Buys
$4.0M
Open-Market Sells
$0
Net Open-Market Flow
$4.0M
Transactions
11
7 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)4.6M——4.6M
Apr 20, 2026Conversion(C)922K——5.5M
Apr 20, 2026Other(J)5.5M——0
Apr 20, 2026Other(J)5.5M——5.5M
Apr 20, 2026Conversion(C)346K——5.9M
Apr 20, 2026Conversion(C)272K——272K
Apr 20, 2026Buy(P)235K$17.00$4.0M507K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)3.2M—$00
Apr 20, 2026Conversion(C)2.9M—$00
Apr 20, 2026Conversion(C)2.1M—$00
Apr 20, 2026Conversion(C)5.0M—$00

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-164634) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML